FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016753743> ?p ?o ?g. }

• W2016753743 endingPage "127" @default.
• W2016753743 startingPage "113" @default.
• W2016753743 abstract "Small cell lung cancer comprises a histologic sub-group of bronchogenic carcinomas distinguished particularly by a responsiveness to cytotoxic agents, and equally by a strong tendency to disseminate, both to mediastinal and distant sites. At one time considered suitable only for short-term palliation by radiation therapy, this disease is now managed by both systemic and regional approaches, typically with close integration of radiotherapy and chemotherapy. Thoracic irradiation produces modest improvements in both survival and local control in small cell lung cancer, when the clinical extent is limited to the chest. The optimal parameters of dose, treatment volume, fractionation, and temporal integration with chemotherapy are not yet defined. When the disease is more extensive radiotherapy plays a useful palliative role. New biological insights are being brought to the clinic, and have stimulated new therapeutic initiatives in the treatment of this disease. Modified radiotherapy fractionation schemes and sophisticated integration of chemotherapy and radiation therapy have resulted in further advances. In addition to improved response rates and median survivals, combined modality approaches suggest, in addition, the possibility of cured subset in cases of disease confined to the chest. The adverse effects of thoracic irradiation are manageable and the more serious can be prevented with careful attention to volume and technique. Radiotherapy offers relief of many symptoms and cost-effective palliation of metastatic lesions in most body sites. Considered as a significant problem in oncology, and apart from efforts at primary prevention, major progress in this disease is most likely to result from research focussed on the limited disease subset, which, unfortunately, consists of no more than half the incident cases. These patients have a median survival of 12–18 months, and are sufficiently numerous that it is possible to detect meaningful treatment progress in clinical trials of a reasonable size. Nevertheless, the marked advances of two decades ago, when chemotherapy first came into widespread use, are not seen today. Progress is now more likely to be seen in modest improvements in survival or tumor control rates when control and experimental regimens are compared statistically in large trials or in meta-analyses. While the evidence supports the use of thoracic radiotherapy the ideal drug combination is unknown, and there is a real need for new agents of substantially greater activity than those available today. While more rational combinations of agents may be possible, it seems likely that the limits of tolerance are being reached. None the less, persistent efforts by many groups has led to an accumulation of modest improvements which have brought real benefit to these patients, and this may be expected to continue. Only the optimal use of local and systemic treatment modalities is likely to significantly improve the outlook for the patient with small cell lung cancer." @default.
• W2016753743 created "2016-06-24" @default.
• W2016753743 creator A5061893135 @default.
• W2016753743 date "1994-04-01" @default.
• W2016753743 modified "2023-09-27" @default.
• W2016753743 title "The role of radiation oncology in small cell lung cancer" @default.
• W2016753743 cites W1868305875 @default.
• W2016753743 cites W1885320430 @default.
• W2016753743 cites W1905406155 @default.
• W2016753743 cites W1923792259 @default.
• W2016753743 cites W1935482218 @default.
• W2016753743 cites W1938763320 @default.
• W2016753743 cites W1951176292 @default.
• W2016753743 cites W1966715368 @default.
• W2016753743 cites W1967655634 @default.
• W2016753743 cites W1976276185 @default.
• W2016753743 cites W1978517514 @default.
• W2016753743 cites W1981900821 @default.
• W2016753743 cites W1986382059 @default.
• W2016753743 cites W1989315499 @default.
• W2016753743 cites W1995606594 @default.
• W2016753743 cites W1995975133 @default.
• W2016753743 cites W2001025782 @default.
• W2016753743 cites W2006676410 @default.
• W2016753743 cites W2010426855 @default.
• W2016753743 cites W2010947937 @default.
• W2016753743 cites W2013808387 @default.
• W2016753743 cites W2017217585 @default.
• W2016753743 cites W2018769622 @default.
• W2016753743 cites W2019223382 @default.
• W2016753743 cites W2020057881 @default.
• W2016753743 cites W2027280653 @default.
• W2016753743 cites W2032142535 @default.
• W2016753743 cites W2047842438 @default.
• W2016753743 cites W2051633138 @default.
• W2016753743 cites W2055210271 @default.
• W2016753743 cites W2058656025 @default.
• W2016753743 cites W2060079855 @default.
• W2016753743 cites W2061243548 @default.
• W2016753743 cites W2061400461 @default.
• W2016753743 cites W2064427333 @default.
• W2016753743 cites W2067550511 @default.
• W2016753743 cites W2072729835 @default.
• W2016753743 cites W2076773100 @default.
• W2016753743 cites W2077210792 @default.
• W2016753743 cites W2080193710 @default.
• W2016753743 cites W2084041928 @default.
• W2016753743 cites W2085622979 @default.
• W2016753743 cites W2089016789 @default.
• W2016753743 cites W2091732713 @default.
• W2016753743 cites W2093511819 @default.
• W2016753743 cites W2103926757 @default.
• W2016753743 cites W2107829252 @default.
• W2016753743 cites W2121624379 @default.
• W2016753743 cites W2122048363 @default.
• W2016753743 cites W2150339765 @default.
• W2016753743 cites W2158034304 @default.
• W2016753743 cites W2160552840 @default.
• W2016753743 cites W2243683089 @default.
• W2016753743 cites W2257045704 @default.
• W2016753743 cites W2263784898 @default.
• W2016753743 cites W2285138158 @default.
• W2016753743 cites W2310145040 @default.
• W2016753743 cites W2329793926 @default.
• W2016753743 cites W2341745217 @default.
• W2016753743 cites W4239010479 @default.
• W2016753743 cites W4242042403 @default.
• W2016753743 cites W4246224720 @default.
• W2016753743 doi "https://doi.org/10.1016/1040-8428(94)90044-2" @default.
• W2016753743 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8068211" @default.
• W2016753743 hasPublicationYear "1994" @default.
• W2016753743 type Work @default.
• W2016753743 sameAs 2016753743 @default.
• W2016753743 citedByCount "5" @default.
• W2016753743 countsByYear W20167537432012 @default.
• W2016753743 crossrefType "journal-article" @default.
• W2016753743 hasAuthorship W2016753743A5061893135 @default.
• W2016753743 hasConcept C121608353 @default.
• W2016753743 hasConcept C126322002 @default.
• W2016753743 hasConcept C143998085 @default.
• W2016753743 hasConcept C2776256026 @default.
• W2016753743 hasConcept C2776694085 @default.
• W2016753743 hasConcept C2779134260 @default.
• W2016753743 hasConcept C509974204 @default.
• W2016753743 hasConcept C71924100 @default.
• W2016753743 hasConceptScore W2016753743C121608353 @default.
• W2016753743 hasConceptScore W2016753743C126322002 @default.
• W2016753743 hasConceptScore W2016753743C143998085 @default.
• W2016753743 hasConceptScore W2016753743C2776256026 @default.
• W2016753743 hasConceptScore W2016753743C2776694085 @default.
• W2016753743 hasConceptScore W2016753743C2779134260 @default.
• W2016753743 hasConceptScore W2016753743C509974204 @default.
• W2016753743 hasConceptScore W2016753743C71924100 @default.
• W2016753743 hasIssue "2" @default.
• W2016753743 hasLocation W20167537431 @default.
• W2016753743 hasLocation W20167537432 @default.
• W2016753743 hasOpenAccess W2016753743 @default.
• W2016753743 hasPrimaryLocation W20167537431 @default.

• next